Literature DB >> 18315706

The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.

Srinivas Sanjay1, Rajeev A Annigeri, Rajagopalan Seshadri, Budithi Subba Rao, Kowdle C Prakash, Muthu Krishna Mani.   

Abstract

AIM: To compare natriuretic, kaliuretic, diuretic and free water clearance efficacy of continuous versus bolus intravenous furosemide administration in patients with chronic renal insufficiency.
MATERIAL AND METHODS: In a prospective randomized cross-over trial, 42 patients of chronic renal insufficiency were randomized to receive the same dose of intravenous furosemide as bolus and continuous infusion. The effects of bolus and intravenous administration of furosemide on the volume of urine, sodium and potassium excretion were assessed.
RESULTS: Mean age was 53.6 +/- 14 years and 23 (55%) were male. The mean modification of diet in renal disease glomerular filtration rate was 20.5 +/- 17 mL/min per 1.73 m(2). The urinary excretion of sodium in intravenous bolus and infusion was 98.1 +/- 78 and 114.4 +/- 100 mmol, respectively (P = 0.001). Total urinary volume following bolus and infusion of furosemide was 1064 +/- 627 and 1170 +/- 764 mL, respectively (0.001). The excretion of potassium was similar in bolus (15.8 +/- 16.6) and infusion (14.3 +/- 9) administration (P = 0.11). The fractional excretion of sodium was higher following infusion (16.63 +/- 16.1) than bolus administration (12.87 +/- 9) of furosemide (P = 0.016).
CONCLUSION: Continuous intravenous infusion of furosemide has significantly better natriuretic and diuretic effect than bolus administration of the same dose of the drug in patients with advanced chronic renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18315706     DOI: 10.1111/j.1440-1797.2007.00889.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  4 in total

1.  Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis.

Authors:  Helton P Lemes; Salustiano Araujo; Daniella Nascimento; Danny Cunha; Cesar Garcia; Vinicius Queiroz; Sebastião R Ferreira-Filho
Journal:  Clin Exp Nephrol       Date:  2011-03-18       Impact factor: 2.801

2.  Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial.

Authors:  Simone Frea; Stefano Pidello; Alessandra Volpe; Federico Giovanni Canavosio; Alessandro Galluzzo; Virginia Bovolo; Antonio Camarda; Pier Giorgio Golzio; Fabrizio D'Ascenzo; Serena Bergerone; Mauro Rinaldi; Fiorenzo Gaita
Journal:  Clin Res Cardiol       Date:  2019-06-29       Impact factor: 5.460

3.  Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction.

Authors:  Zhigui Zheng; Xinxin Jiang; Jianguo Chen; Dongyuan He; Xiaohui Xie; Yunan Lu
Journal:  ESC Heart Fail       Date:  2021-03-10

4.  Goal-directed diuresis: A case - control study of continuous furosemide infusion in critically ill trauma patients.

Authors:  Daniel Dante Yeh; Gwendolyn M Van Der Wilden; Catrina Cropano; Yuchiao Chang; David R King; Marc De Moya; Peter Fagenholz; Haytham Kaafarani; Jarone Lee; George Velmahos
Journal:  J Emerg Trauma Shock       Date:  2015 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.